All Sessions Welcome and Opening Remarks, Keynote Address  Nanomedicine: Nonclinical and Clinical Implications  Use of Animal Models of Disease for Preclinical Evaluation of Safety and Efficacy  Dose Exposure Response Issues: Biologics vs. Small Molecules  Emerging Techologies For Cancer Diagnosis and Treatment  The Public Health Significance of Pathogens: BSE/TSE  Challenges in Post-marketing Management of Risk and its Evaluation in the General Population  Meet the Center Directors, The Science behind the Headlines: A Conversation with the FDA Center Directors  Integration of Pharmacogenetics and Pharmacogenomics into Drug Development and Clinical Practice  Predictive Models for Bioavailability and Effectiveness  Clinical Biomarkers in Biologics and Drug Development: Efficacy Assessment and Pharmacodynamics  Product Manufacturing Science: Process and Quality Control  Genetically Engineered Food  Emerging Infectious Diseases and Bioterrorism - Preparing for Timely Approval of Safe and Effective Antimicrobiologicals, Vaccines, and Antisera  Safety Systems for Biologics  Bioengineering of Cells and Tissues  Nonclinical Toxicogenomic Studies and Challenges in Molecular Risk Assessment  Adaptive Study Designs to Meet Special Challenges in the Measurement of Efficacy and Safety  Delivery for Drugs and Biologics: Biomaterials Science and Engineering  Emerging Analytical Technology for Detecting Toxins  FDA Leveraging Program    Webcast produced by Prous Science © Prous Science 2005. RealNetworks, RealPlayer and RealAudio are trademarks of RealNetworks, Inc.